Even if it is the actual drug, the doses can be too high
I'll link to these studies for you
It all happened on March 21, a day after Danish pharma major Novo Nordisks patent protection for its blockbuster diabetes and weight-loss drug, Semaglutide, expired in India
Use our educational peptide calculators to better understand units, mL, concentration, reconstitution, and vial calculations
For some patients, weight regain despite intensive lifestyle efforts may warrant consideration of resuming tirzepatide or transitioning to alternative anti-obesity medications, provided they meet FDA-indicated criteria (BMI 30 kg/m or 27 kg/m with weight-related comorbidity)
So which will you be more likely to take consistently